COVID-19
U.S. Sets Record With Over 1 Million New Daily Covid-19 Cases
Experts credit the recent surge to the spreading omicron variant and a lag in case reporting over the holidays
How Shark Antibodies Could Aid the Fight Against Coronavirus and Prepare for Future Outbreaks
The protein-like immune molecules were found to block SARS-Cov-2 from entering human cells
The Ten Most Significant Science Stories of 2021
Thrilling discoveries, hurdles in the fight against Covid and advancements in space exploration defined the past year
Our Top Ten Stories of 2021
From archaeological finds to an invasive weed to Roman bathrooms, these were our most-read articles of the year
The CDC Now Recommends Pfizer and Moderna Covid-19 Vaccines Over J&J
The decision comes after more evidence linking the Johnson & Johnson shot to a rare blood clotting syndrome
Pfizer Says Covid-19 Pill Is Effective and Likely Works Against Omicron
The drug helps those already infected, but experts say vaccination is the best way to prevent contracting and spreading the virus
The Ten Best Science Books of 2021
From captivating memoirs by researchers to illuminating narratives by veteran science journalists, these works affected us the most this year
Searching for Curry and Enlightenment on the Indian Buffet Line
A return to trays of glistening tandoori and hand-rolled naan for the first time since the start of the Covid-19 pandemic is a return to normalcy
Could This Chewing Gum Reduce the Spread of Covid-19?
Preliminary results show the viral load in infected saliva was reduced viral load by 95 percent, but the research has a long way to go
Six Questions About Waning Immunity to Covid-19 Answered
Experts weigh in on when a reduced immune response occurs and how boosters can help restore defenses
What Experts Do and Don't Know About the Omicron Covid-19 Variant
Scientists have dubbed Omicron a “variant of concern,” but warn against panic
Up to 1.6 Million People in the U.S. Have Long-Term Smell Loss Due to Covid-19
After six months of smell loss, the chance of recovery drops to less than 20 percent, and around 5 percent of all cases will result in permanent loss
CDC Panel and FDA Authorize Covid-19 Boosters for All Adults
Americans 18 and older will be eligible for a booster shot of their choice, pending approval from CDC Director Rochelle Walensky
Pfizer Asks FDA to Expand Booster Eligibility to All Adults
Experts are optimistic the request will be granted before the winter holiday season
Pfizer Says Covid-19 Pill Cuts Hospitalization and Death Risk by Nearly 90 Percent
Though vaccines are still the best line of defense against the virus, the antiviral drug could help high-risk Americans once symptoms appear
CDC Recommends Pfizer's Covid-19 Vaccine for Children Ages 5 to 11
About 28 million kids are immediately eligible for the safe and effective lower-dose vaccine
FDA Authorizes Pfizer's Covid-19 Vaccine for Kids 5 to 11
The lower-dose vaccine could be administered as soon as this Wednesday, pending CDC approval
The CDC Adds Mental Health Conditions to High-Risk Covid-19 List
The addition of mood disorders expands the list of Americans eligible for booster shots by millions
Could Skin Patches Be the Future of Covid Vaccines?
The device might survive longer storage times and pose a better option for people afraid of needles
Mixing and Matching Covid-19 Vaccines Could Impact Immunity
Because public health officials aren’t recommending one booster shot over another, individuals are left to make a choice based on personal factors
Page 6 of 28